Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$165.67 - $199.94 $15,738 - $18,994
-95 Reduced 26.39%
265 $44,000
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $39,980 - $52,823
-264 Reduced 73.33%
96 $18,000
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $78,143 - $103,246
-516 Reduced 58.9%
360 $71,000
Q3 2023

Nov 09, 2023

BUY
$167.14 - $192.77 $146,414 - $168,866
876 New
876 $152,000
Q1 2021

May 10, 2021

SELL
$144.0 - $169.39 $288,000 - $338,780
-2,000 Closed
0 $0
Q4 2020

Feb 05, 2021

BUY
$157.07 - $174.35 $313,040 - $347,479
1,993 Added 28471.43%
2,000 $331,000
Q3 2020

Nov 12, 2020

BUY
$137.1 - $165.37 $959 - $1,157
7 New
7 $1,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Rational Advisors LLC Portfolio

Follow Rational Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rational Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rational Advisors LLC with notifications on news.